> top > docs > PMC:7461127 > annotations

PMC:7461127 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 296-305 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T2 425-448 Body_part denotes lower respiratory tract http://purl.org/sig/ont/fma/fma45662
T3 456-469 Body_part denotes organ systems http://purl.org/sig/ont/fma/fma7149
T4 456-461 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T5 517-521 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T6 618-624 Body_part denotes serine http://purl.org/sig/ont/fma/fma82764
T7 814-818 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T8 1034-1043 Body_part denotes platelets http://purl.org/sig/ont/fma/fma62851
T9 1331-1338 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T10 1365-1373 Body_part denotes heparins http://purl.org/sig/ont/fma/fma82839
T11 1670-1676 Body_part denotes Tissue http://purl.org/sig/ont/fma/fma9637
T12 2860-2866 Body_part denotes serine http://purl.org/sig/ont/fma/fma82764
T13 2906-2909 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T14 3487-3492 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T15 3719-3742 Body_part denotes lower respiratory tract http://purl.org/sig/ont/fma/fma45662
T16 3786-3799 Body_part denotes organ systems http://purl.org/sig/ont/fma/fma7149
T17 3786-3791 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T18 3843-3858 Body_part denotes nervous systems http://purl.org/sig/ont/fma/fma7157
T19 3941-3945 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T20 4065-4098 Body_part denotes the endothelial cells of arteries http://purl.org/sig/ont/fma/fma67761
T21 4069-4086 Body_part denotes endothelial cells http://purl.org/sig/ont/fma/fma66772
T22 4081-4086 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T23 4090-4098 Body_part denotes arteries http://purl.org/sig/ont/fma/fma63812
T24 4103-4108 Body_part denotes veins http://purl.org/sig/ont/fma/fma63814
T25 4119-4138 Body_part denotes smooth muscle cells http://purl.org/sig/ont/fma/fma14072
T26 4133-4138 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T27 4163-4181 Body_part denotes alveolar epithelia http://purl.org/sig/ont/fma/fma63915
T28 4172-4181 Body_part denotes epithelia http://purl.org/sig/ont/fma/fma9639
T29 4182-4187 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T30 4197-4201 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T31 4202-4208 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T32 4271-4278 Body_part denotes tissues http://purl.org/sig/ont/fma/fma9637
T33 4435-4441 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T34 4513-4517 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T35 4518-4524 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T36 4592-4610 Body_part denotes respiratory system http://purl.org/sig/ont/fma/fma7158
T37 4654-4659 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T38 4961-4983 Body_part denotes gastrointestinal tract http://purl.org/sig/ont/fma/fma71132
T39 4985-4992 Body_part denotes kidneys http://purl.org/sig/ont/fma/fma7203
T40 4994-4999 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T41 5005-5010 Body_part denotes brain http://purl.org/sig/ont/fma/fma50801
T42 5148-5170 Body_part denotes central nervous system http://purl.org/sig/ont/fma/fma55675
T43 5280-5285 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T44 5332-5345 Body_part denotes organ systems http://purl.org/sig/ont/fma/fma7149
T45 5332-5337 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T46 5595-5599 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T47 5600-5611 Body_part denotes endothelium http://purl.org/sig/ont/fma/fma63916
T48 5842-5850 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T49 5989-5994 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T50 6606-6614 Body_part denotes alveolar http://purl.org/sig/ont/fma/fma264783
T51 6652-6663 Body_part denotes pneumocytes http://purl.org/sig/ont/fma/fma62499
T52 6720-6737 Body_part denotes bronchiolar walls http://purl.org/sig/ont/fma/fma74655
T53 6747-6755 Body_part denotes alveolar http://purl.org/sig/ont/fma/fma264783
T54 6770-6778 Body_part denotes alveolar http://purl.org/sig/ont/fma/fma264783
T55 6803-6816 Body_part denotes bronchiolitis http://purl.org/sig/ont/fma/fma76497
T56 6856-6874 Body_part denotes pulmonary arteries http://purl.org/sig/ont/fma/fma66326
T57 6866-6874 Body_part denotes arteries http://purl.org/sig/ont/fma/fma63812
T58 7301-7309 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T59 7405-7410 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T60 7415-7429 Body_part denotes megakaryocytes http://purl.org/sig/ont/fma/fma83555
T61 7448-7457 Body_part denotes platelets http://purl.org/sig/ont/fma/fma62851
T62 7634-7642 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T63 8418-8427 Body_part denotes platelets http://purl.org/sig/ont/fma/fma62851
T64 8429-8446 Body_part denotes endothelial cells http://purl.org/sig/ont/fma/fma66772
T65 8441-8446 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T66 8452-8462 Body_part denotes leukocytes http://purl.org/sig/ont/fma/fma62852
T67 8508-8514 Body_part denotes serine http://purl.org/sig/ont/fma/fma82764
T68 9316-9323 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T69 9368-9376 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T70 9463-9471 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T71 10042-10050 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T72 11498-11509 Body_part denotes endothelium http://purl.org/sig/ont/fma/fma63916
T73 11549-11556 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T74 12046-12053 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T75 12152-12160 Body_part denotes heparins http://purl.org/sig/ont/fma/fma82839
T76 12233-12240 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T77 12546-12554 Body_part denotes heparins http://purl.org/sig/ont/fma/fma82839
T78 12622-12629 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T79 12812-12816 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T80 13027-13034 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T81 13044-13048 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T82 13088-13095 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T83 13141-13149 Body_part denotes heparins http://purl.org/sig/ont/fma/fma82839
T84 13237-13241 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T85 13377-13385 Body_part denotes heparins http://purl.org/sig/ont/fma/fma82839
T86 13397-13401 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T87 13402-13408 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T88 13493-13500 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T89 13530-13548 Body_part denotes glycosaminoglycans http://purl.org/sig/ont/fma/fma63011
T90 13691-13697 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T91 13739-13750 Body_part denotes endothelium http://purl.org/sig/ont/fma/fma63916
T92 13938-13945 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T93 14319-14328 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T94 15252-15258 Body_part denotes Tissue http://purl.org/sig/ont/fma/fma9637
T95 16050-16055 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T96 16166-16170 Body_part denotes calf http://purl.org/sig/ont/fma/fma24984
T97 16416-16422 Body_part denotes muscle http://purl.org/sig/ont/fma/fma32558
T98 16662-16666 Body_part denotes calf http://purl.org/sig/ont/fma/fma24984
T99 16671-16675 Body_part denotes foot http://purl.org/sig/ont/fma/fma9664
T100 16708-16720 Body_part denotes venous blood http://purl.org/sig/ont/fma/fma83067
T101 16732-16737 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T102 16745-16749 Body_part denotes calf http://purl.org/sig/ont/fma/fma24984
T103 16750-16757 Body_part denotes muscles http://purl.org/sig/ont/fma/fma32558
T104 16837-16843 Body_part denotes muscle http://purl.org/sig/ont/fma/fma32558
T105 16844-16868 Body_part denotes bellies of gastrocnemius http://purl.org/sig/ont/fma/fma45951
T106 16855-16868 Body_part denotes gastrocnemius http://purl.org/sig/ont/fma/fma22541
T107 16892-16913 Body_part denotes common peroneal nerve http://purl.org/sig/ont/fma/fma19039
T108 17579-17597 Body_part denotes pulmonary arteries http://purl.org/sig/ont/fma/fma66326
T109 17589-17597 Body_part denotes arteries http://purl.org/sig/ont/fma/fma63812
T110 17768-17781 Body_part denotes interleukin 6 http://purl.org/sig/ont/fma/fma264829
T111 17768-17779 Body_part denotes interleukin http://purl.org/sig/ont/fma/fma86578
T112 18546-18552 Body_part denotes Plasma http://purl.org/sig/ont/fma/fma62970
T113 18608-18614 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T114 18694-18700 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T115 18733-18739 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T116 19021-19027 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T117 19196-19202 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T118 19291-19297 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T119 19402-19407 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T120 19564-19569 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T121 19758-19776 Body_part denotes bronchial arteries http://purl.org/sig/ont/fma/fma68109
T122 19768-19776 Body_part denotes arteries http://purl.org/sig/ont/fma/fma63812
T123 19983-19988 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T124 19997-20015 Body_part denotes bronchial arteries http://purl.org/sig/ont/fma/fma68109
T125 20007-20015 Body_part denotes arteries http://purl.org/sig/ont/fma/fma63812
T126 20863-20878 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893
T127 21358-21363 Body_part denotes Heart http://purl.org/sig/ont/fma/fma7088
T128 21451-21456 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T129 21546-21551 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T130 21774-21779 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T131 21848-21853 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T132 23255-23260 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T133 23437-23445 Body_part denotes heparins http://purl.org/sig/ont/fma/fma82839
T134 23563-23571 Body_part denotes heparins http://purl.org/sig/ont/fma/fma82839
T135 23805-23810 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 425-448 Body_part denotes lower respiratory tract http://purl.obolibrary.org/obo/UBERON_0001558
T2 431-448 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T3 456-461 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T4 814-818 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T5 1670-1676 Body_part denotes Tissue http://purl.obolibrary.org/obo/UBERON_0000479
T6 3487-3492 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T7 3719-3742 Body_part denotes lower respiratory tract http://purl.obolibrary.org/obo/UBERON_0001558
T8 3725-3742 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T9 3786-3791 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T10 3843-3858 Body_part denotes nervous systems http://purl.obolibrary.org/obo/UBERON_0001016
T11 4163-4181 Body_part denotes alveolar epithelia http://purl.obolibrary.org/obo/UBERON_0004821
T12 4172-4181 Body_part denotes epithelia http://purl.obolibrary.org/obo/UBERON_0000483
T13 4197-4201 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T14 4202-4208 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T15 4435-4441 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T16 4513-4517 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T17 4518-4524 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T18 4592-4610 Body_part denotes respiratory system http://purl.obolibrary.org/obo/UBERON_0001004
T19 4878-4884 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T20 4994-4999 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T21 5005-5010 Body_part denotes brain http://purl.obolibrary.org/obo/UBERON_0000955
T22 5131-5137 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T23 5148-5170 Body_part denotes central nervous system http://purl.obolibrary.org/obo/UBERON_0001017
T24 5156-5170 Body_part denotes nervous system http://purl.obolibrary.org/obo/UBERON_0001016
T25 5332-5337 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T26 5595-5611 Body_part denotes lung endothelium http://purl.obolibrary.org/obo/UBERON_0013479
T27 5595-5599 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T28 5600-5611 Body_part denotes endothelium http://purl.obolibrary.org/obo/UBERON_0001986
T29 6856-6874 Body_part denotes pulmonary arteries http://purl.obolibrary.org/obo/UBERON_0002012
T30 11498-11509 Body_part denotes endothelium http://purl.obolibrary.org/obo/UBERON_0001986
T31 12812-12816 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T32 13044-13048 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T33 13237-13241 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T34 13397-13401 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T35 13402-13408 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T36 13691-13697 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T37 13739-13750 Body_part denotes endothelium http://purl.obolibrary.org/obo/UBERON_0001986
T38 15252-15258 Body_part denotes Tissue http://purl.obolibrary.org/obo/UBERON_0000479
T39 16050-16055 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T40 16671-16675 Body_part denotes foot http://purl.obolibrary.org/obo/UBERON_0002387
T41 16708-16720 Body_part denotes venous blood http://purl.obolibrary.org/obo/UBERON_0013756
T42 16715-16720 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T43 16732-16737 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T44 16855-16868 Body_part denotes gastrocnemius http://purl.obolibrary.org/obo/UBERON_0001388
T45 16908-16913 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T46 17579-17597 Body_part denotes pulmonary arteries http://purl.obolibrary.org/obo/UBERON_0002012
T47 19564-19569 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T48 19758-19776 Body_part denotes bronchial arteries http://purl.obolibrary.org/obo/UBERON_0002040
T49 19997-20015 Body_part denotes bronchial arteries http://purl.obolibrary.org/obo/UBERON_0002040
T50 20863-20878 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T51 20872-20878 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T52 21358-21363 Body_part denotes Heart http://purl.obolibrary.org/obo/UBERON_0000948
T53 21451-21456 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T54 21546-21551 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T55 21774-21779 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T56 21848-21853 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T57 23805-23810 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 6-18 Disease denotes Coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T2 36-44 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 75-83 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 160-168 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T5 382-390 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T6 489-497 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T7 700-708 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T8 719-731 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T9 746-764 Disease denotes pulmonary embolism http://purl.obolibrary.org/obo/MONDO_0005279
T10 802-812 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T11 831-837 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T12 890-925 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T13 896-925 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T14 933-945 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T15 991-995 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T16 1127-1165 Disease denotes disseminated intravascular coagulation http://purl.obolibrary.org/obo/MONDO_0001243
T17 1246-1254 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T18 1412-1420 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T19 1846-1864 Disease denotes pulmonary embolism http://purl.obolibrary.org/obo/MONDO_0005279
T20 1986-1994 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T21 2078-2086 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T22 2579-2587 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T23 3134-3169 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T24 3140-3169 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T25 3171-3175 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T26 3182-3193 Disease denotes pneumonitis http://purl.obolibrary.org/obo/MONDO_0043905
T27 3239-3247 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T28 3307-3319 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T29 3410-3418 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T30 3639-3647 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T31 3650-3659 Disease denotes Infection http://purl.obolibrary.org/obo/MONDO_0005550
T32 3661-3669 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T33 3671-3679 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T34 4376-4386 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T35 4623-4631 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T36 4661-4669 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T37 4838-4842 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T38 4912-4920 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T39 5070-5078 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T40 5174-5182 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T41 5200-5212 Disease denotes Coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T42 5222-5230 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T43 5287-5295 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T44 5420-5428 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T45 5469-5487 Disease denotes pulmonary embolism http://purl.obolibrary.org/obo/MONDO_0005279
T46 5489-5491 Disease denotes PE http://purl.obolibrary.org/obo/MONDO_0005279
T47 5535-5545 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T48 5585-5591 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T49 5748-5764 Disease denotes Viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T50 5852-5860 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T51 5887-5909 Disease denotes respiratory infections http://purl.obolibrary.org/obo/MONDO_0024355
T52 5998-6016 Disease denotes Pulmonary infarcts http://purl.obolibrary.org/obo/MONDO_0004597
T53 6021-6037 Disease denotes thrombocytopenia http://purl.obolibrary.org/obo/MONDO_0002049
T54 6055-6063 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T55 6137-6141 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T56 6253-6262 Disease denotes swine flu http://purl.obolibrary.org/obo/MONDO_0005460
T57 6259-6262 Disease denotes flu http://purl.obolibrary.org/obo/MONDO_0005812
T58 6363-6371 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T59 6465-6480 Disease denotes viral pneumonia http://purl.obolibrary.org/obo/MONDO_0006012
T60 6471-6480 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T61 6502-6514 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T62 6629-6640 Disease denotes hyperplasia http://purl.obolibrary.org/obo/MONDO_0005043
T63 6672-6680 Disease denotes thrombus http://purl.obolibrary.org/obo/MONDO_0000831
T64 6803-6816 Disease denotes bronchiolitis http://purl.obolibrary.org/obo/MONDO_0002465
T65 6832-6842 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T66 7288-7292 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T67 7360-7369 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T68 7471-7515 Disease denotes disseminated intravascular coagulation (DIC) http://purl.obolibrary.org/obo/MONDO_0001243
T69 7581-7597 Disease denotes thrombocytopenia http://purl.obolibrary.org/obo/MONDO_0002049
T70 7601-7609 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T71 7687-7702 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T72 7693-7702 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T73 7792-7800 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T74 7881-7897 Disease denotes thrombocytopenia http://purl.obolibrary.org/obo/MONDO_0002049
T75 7938-7954 Disease denotes thrombocytopenia http://purl.obolibrary.org/obo/MONDO_0002049
T76 8092-8102 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T77 8227-8243 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T78 8596-8612 Disease denotes Viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T79 8811-8819 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T80 8965-8973 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T81 8998-9018 Disease denotes thrombotic disorders http://purl.obolibrary.org/obo/MONDO_0000831
T82 9124-9134 Disease denotes Thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T83 9204-9216 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T84 9220-9228 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T85 9612-9620 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T86 9715-9723 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T87 10504-10526 Disease denotes venous thromboembolism http://purl.obolibrary.org/obo/MONDO_0005399
T88 10528-10531 Disease denotes VTE http://purl.obolibrary.org/obo/MONDO_0005399
T89 10549-10557 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T90 10558-10567 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T91 10763-10771 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T92 10783-10786 Disease denotes VTE http://purl.obolibrary.org/obo/MONDO_0005399
T93 10866-10869 Disease denotes VTE http://purl.obolibrary.org/obo/MONDO_0005399
T94 11152-11160 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T95 11247-11264 Disease denotes venous thrombosis http://purl.obolibrary.org/obo/MONDO_0008559
T96 11254-11264 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T97 11271-11279 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T98 11609-11617 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T99 11908-11916 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T100 12110-12118 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T101 12292-12308 Disease denotes thrombocytopenia http://purl.obolibrary.org/obo/MONDO_0002049
T102 12588-12596 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T103 12817-12823 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T104 12943-12952 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T105 13038-13055 Disease denotes acute lung injury http://purl.obolibrary.org/obo/MONDO_0006502|http://purl.obolibrary.org/obo/MONDO_0015796
T107 13049-13055 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T108 13189-13226 Disease denotes chronic obstructive pulmonary disease http://purl.obolibrary.org/obo/MONDO_0005002
T109 13209-13226 Disease denotes pulmonary disease http://purl.obolibrary.org/obo/MONDO_0005275
T110 13237-13250 Disease denotes lung diseases http://purl.obolibrary.org/obo/MONDO_0005275
T111 13270-13276 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T112 13290-13298 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T113 13299-13314 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T114 13305-13314 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T115 13348-13354 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T116 14439-14447 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T117 15005-15013 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T118 15305-15313 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T119 15325-15329 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T120 15793-15799 Disease denotes stroke http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057
T122 16028-16034 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T123 16576-16586 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T124 16979-16982 Disease denotes VTE http://purl.obolibrary.org/obo/MONDO_0005399
T125 17021-17029 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T126 17116-17118 Disease denotes PE http://purl.obolibrary.org/obo/MONDO_0005279
T127 17122-17130 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T128 17193-17195 Disease denotes PE http://purl.obolibrary.org/obo/MONDO_0005279
T129 17199-17207 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T130 17504-17507 Disease denotes CDT http://purl.obolibrary.org/obo/MONDO_0011818
T131 17911-17913 Disease denotes PE http://purl.obolibrary.org/obo/MONDO_0005279
T132 18068-18076 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T133 18670-18678 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T134 19319-19327 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T135 19512-19547 Disease denotes Acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T136 19518-19547 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T137 20126-20134 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T138 20385-20393 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T139 20575-20583 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T140 20695-20703 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T141 20704-20713 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T142 20840-20848 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T143 20863-20886 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T144 20872-20886 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T145 20888-20891 Disease denotes CAD http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922
T147 21002-21010 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T148 21331-21339 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T149 21364-21370 Disease denotes Injury http://purl.obolibrary.org/obo/MONDO_0021178
T150 21422-21430 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T151 21457-21463 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T152 21552-21558 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T153 21780-21786 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T154 21793-21801 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T155 21854-21860 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T156 22041-22047 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T157 22108-22131 Disease denotes acute coronary syndrome http://purl.obolibrary.org/obo/MONDO_0005542
T158 22150-22153 Disease denotes CAD http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922
T160 22258-22280 Disease denotes cardiovascular disease http://purl.obolibrary.org/obo/MONDO_0004995
T161 22466-22472 Disease denotes Stroke http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057
T163 22525-22532 Disease denotes strokes http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057
T165 22558-22566 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T166 22869-22877 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T167 23039-23047 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T168 23162-23170 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T169 23218-23226 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T170 23285-23293 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T171 23811-23817 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T172 23873-23881 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 84-87 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T2 425-448 http://purl.obolibrary.org/obo/UBERON_0001558 denotes lower respiratory tract
T3 456-469 http://purl.obolibrary.org/obo/UBERON_0000467 denotes organ systems
T4 517-521 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T5 774-782 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arterial
T6 774-782 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arterial
T7 814-818 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T8 814-818 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T9 1264-1267 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T10 1677-1688 http://purl.obolibrary.org/obo/PR_000012867 denotes plasminogen
T11 1689-1698 http://purl.obolibrary.org/obo/CLO_0001658 denotes activator
T12 2229-2230 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T13 2252-2255 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T14 3275-3276 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T15 3325-3328 http://purl.obolibrary.org/obo/PR_000001343 denotes aim
T16 3487-3492 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T17 3719-3742 http://purl.obolibrary.org/obo/UBERON_0001558 denotes lower respiratory tract
T18 3786-3799 http://purl.obolibrary.org/obo/UBERON_0000467 denotes organ systems
T19 3885-3888 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T20 3916-3921 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T21 3941-3945 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T22 4069-4086 http://purl.obolibrary.org/obo/CL_0000115 denotes endothelial cells
T23 4090-4098 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arteries
T24 4090-4098 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arteries
T25 4103-4108 http://purl.obolibrary.org/obo/UBERON_0001638 denotes veins
T26 4103-4108 http://www.ebi.ac.uk/efo/EFO_0000816 denotes veins
T27 4110-4118 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arterial
T28 4110-4118 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arterial
T29 4119-4138 http://purl.obolibrary.org/obo/CL_0000192 denotes smooth muscle cells
T30 4182-4187 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T31 4191-4196 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T32 4197-4201 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T33 4197-4201 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T34 4265-4270 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T35 4399-4400 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T36 4429-4434 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T37 4471-4474 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T38 4513-4517 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T39 4513-4517 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T40 4592-4610 http://purl.obolibrary.org/obo/UBERON_0001004 denotes respiratory system
T41 4654-4659 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T42 4878-4884 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T43 4961-4983 http://purl.obolibrary.org/obo/UBERON_0005409 denotes gastrointestinal tract
T44 4985-4992 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidneys
T45 4985-4992 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidneys
T46 4985-4992 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidneys
T47 4994-4999 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T48 4994-4999 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T49 4994-4999 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T50 4994-4999 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T51 5005-5010 http://purl.obolibrary.org/obo/UBERON_0000955 denotes brain
T52 5005-5010 http://www.ebi.ac.uk/efo/EFO_0000302 denotes brain
T53 5012-5013 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T54 5131-5137 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T55 5148-5170 http://purl.obolibrary.org/obo/UBERON_0001017 denotes central nervous system
T56 5148-5170 http://www.ebi.ac.uk/efo/EFO_0000302 denotes central nervous system
T57 5148-5170 http://www.ebi.ac.uk/efo/EFO_0000908 denotes central nervous system
T58 5280-5285 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T59 5296-5299 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T60 5332-5345 http://purl.obolibrary.org/obo/UBERON_0000467 denotes organ systems
T61 5504-5512 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arterial
T62 5504-5512 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arterial
T63 5595-5599 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T64 5595-5599 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T65 5600-5611 http://purl.obolibrary.org/obo/UBERON_0001986 denotes endothelium
T66 5989-5994 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T67 5995-5997 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T68 6244-6249 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T69 6803-6816 http://purl.obolibrary.org/obo/UBERON_0002186 denotes bronchiolitis
T70 6856-6874 http://purl.obolibrary.org/obo/UBERON_0002012 denotes pulmonary arteries
T71 6856-6874 http://www.ebi.ac.uk/efo/EFO_0001399 denotes pulmonary arteries
T72 6900-6902 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T73 6903-6904 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T74 7060-7068 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arterial
T75 7060-7068 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arterial
T76 7405-7410 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T77 7542-7543 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T78 7803-7806 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T79 7864-7867 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T80 8244-8247 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T81 8429-8446 http://purl.obolibrary.org/obo/CL_0000115 denotes endothelial cells
T82 8593-8595 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T83 8613-8616 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T84 8709-8712 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T85 9293-9294 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T86 9347-9353 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T87 9366-9367 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T88 9445-9456 http://purl.obolibrary.org/obo/PR_000007299 denotes prothrombin
T89 9753-9754 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T90 9776-9779 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T91 9879-9880 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T92 10569-10570 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T93 11289-11292 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T94 11462-11463 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T95 11485-11490 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T96 11498-11509 http://purl.obolibrary.org/obo/UBERON_0001986 denotes endothelium
T97 11858-11861 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T98 12128-12130 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T99 12251-12252 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T100 12630-12633 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T101 12734-12736 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T102 12740-12741 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T103 12812-12816 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T104 12812-12816 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T105 12824-12827 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T106 12870-12873 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T107 12998-12999 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T108 13044-13048 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T109 13044-13048 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T110 13237-13241 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T111 13237-13241 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T112 13397-13401 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T113 13397-13401 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T114 13504-13505 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T115 13739-13750 http://purl.obolibrary.org/obo/UBERON_0001986 denotes endothelium
T116 14132-14133 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T117 15072-15073 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T118 15259-15270 http://purl.obolibrary.org/obo/PR_000012867 denotes plasminogen
T119 15271-15280 http://purl.obolibrary.org/obo/CLO_0001658 denotes activator
T120 15282-15285 http://purl.obolibrary.org/obo/CLO_0053275 denotes tPA
T121 15282-15285 http://purl.obolibrary.org/obo/CLO_0053276 denotes tPA
T122 15282-15285 http://purl.obolibrary.org/obo/CLO_0053277 denotes tPA
T123 15287-15290 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T124 16050-16055 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T125 16050-16055 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T126 16065-16067 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T127 16166-16170 http://www.ebi.ac.uk/efo/EFO_0003051 denotes calf
T128 16231-16238 http://purl.obolibrary.org/obo/OBI_0000968 denotes devices
T129 16295-16296 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T130 16416-16422 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscle
T131 16416-16422 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscle
T132 16416-16422 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscle
T133 16416-16422 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscle
T134 16634-16641 http://purl.obolibrary.org/obo/OBI_0000968 denotes devices
T135 16662-16666 http://www.ebi.ac.uk/efo/EFO_0003051 denotes calf
T136 16715-16720 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T137 16715-16720 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T138 16732-16737 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T139 16732-16737 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T140 16732-16737 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T141 16732-16737 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T142 16745-16749 http://www.ebi.ac.uk/efo/EFO_0003051 denotes calf
T143 16750-16757 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscles
T144 16837-16843 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscle
T145 16837-16843 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscle
T146 16837-16843 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscle
T147 16837-16843 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscle
T148 16844-16851 http://purl.obolibrary.org/obo/UBERON_0000916 denotes bellies
T149 16908-16913 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
T150 16963-16964 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T151 17351-17354 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T152 17432-17433 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T153 17551-17552 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T154 17579-17597 http://purl.obolibrary.org/obo/UBERON_0002012 denotes pulmonary arteries
T155 17579-17597 http://www.ebi.ac.uk/efo/EFO_0001399 denotes pulmonary arteries
T156 17768-17781 http://purl.obolibrary.org/obo/PR_000001393 denotes interleukin 6
T157 17870-17877 http://purl.obolibrary.org/obo/OBI_0000968 denotes devices
T158 18112-18117 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T159 18546-18552 http://purl.obolibrary.org/obo/UBERON_0001969 denotes Plasma
T160 18608-18614 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T161 18694-18700 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T162 18733-18739 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T163 18867-18870 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T164 19021-19027 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T165 19196-19202 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T166 19203-19205 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T167 19291-19297 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T168 19402-19407 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T169 19564-19569 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T170 19564-19569 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T171 19768-19776 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arteries
T172 19768-19776 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arteries
T173 19914-19915 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T174 19983-19988 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T175 20007-20015 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arteries
T176 20007-20015 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arteries
T177 20179-20180 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T178 20872-20878 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T179 20872-20878 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T180 21358-21363 http://purl.obolibrary.org/obo/UBERON_0000948 denotes Heart
T181 21358-21363 http://purl.obolibrary.org/obo/UBERON_0007100 denotes Heart
T182 21358-21363 http://purl.obolibrary.org/obo/UBERON_0015228 denotes Heart
T183 21358-21363 http://www.ebi.ac.uk/efo/EFO_0000815 denotes Heart
T184 21451-21456 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T185 21451-21456 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T186 21451-21456 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T187 21451-21456 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T188 21487-21489 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T189 21546-21551 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T190 21546-21551 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T191 21546-21551 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T192 21546-21551 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T193 21671-21678 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T194 21774-21779 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T195 21774-21779 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T196 21774-21779 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T197 21774-21779 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T198 21814-21815 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T199 21848-21853 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T200 21848-21853 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T201 21848-21853 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T202 21848-21853 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T203 22218-22221 http://purl.obolibrary.org/obo/CLO_0053275 denotes tPA
T204 22218-22221 http://purl.obolibrary.org/obo/CLO_0053276 denotes tPA
T205 22218-22221 http://purl.obolibrary.org/obo/CLO_0053277 denotes tPA
T206 22502-22503 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T207 22673-22676 http://purl.obolibrary.org/obo/CLO_0053275 denotes tPA
T208 22673-22676 http://purl.obolibrary.org/obo/CLO_0053276 denotes tPA
T209 22673-22676 http://purl.obolibrary.org/obo/CLO_0053277 denotes tPA
T210 22768-22775 http://purl.obolibrary.org/obo/OBI_0000968 denotes devices
T211 22991-22992 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T212 23255-23260 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T213 23312-23313 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T214 23805-23810 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T215 23805-23810 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T216 23805-23810 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T217 23805-23810 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T218 24711-24712 http://purl.obolibrary.org/obo/CLO_0001020 denotes A

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 559-570 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T2 618-624 Chemical denotes serine http://purl.obolibrary.org/obo/CHEBI_17822
T3 1307-1321 Chemical denotes anticoagulants http://purl.obolibrary.org/obo/CHEBI_50249
T4 1331-1338 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T5 1365-1373 Chemical denotes heparins http://purl.obolibrary.org/obo/CHEBI_24505
T6 1451-1464 Chemical denotes anticoagulant http://purl.obolibrary.org/obo/CHEBI_50249
T7 1508-1517 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T8 1578-1592 Chemical denotes anticoagulants http://purl.obolibrary.org/obo/CHEBI_50249
T9 2686-2696 Chemical denotes antivirals http://purl.obolibrary.org/obo/CHEBI_22587
T10 2754-2765 Chemical denotes Angiotensin http://purl.obolibrary.org/obo/CHEBI_2719
T11 2785-2796 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T12 2825-2835 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T13 2860-2866 Chemical denotes serine http://purl.obolibrary.org/obo/CHEBI_17822
T14 2879-2889 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T15 2933-2949 Chemical denotes antiviral agents http://purl.obolibrary.org/obo/CHEBI_22587
T16 3007-3025 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T17 3546-3559 Chemical denotes anticoagulant http://purl.obolibrary.org/obo/CHEBI_50249
T18 4160-4162 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T19 5489-5491 Chemical denotes PE http://purl.obolibrary.org/obo/CHEBI_16038|http://purl.obolibrary.org/obo/CHEBI_17553|http://purl.obolibrary.org/obo/CHEBI_74762
T22 5842-5850 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T23 6649-6651 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T24 7511-7514 Chemical denotes DIC http://purl.obolibrary.org/obo/CHEBI_4305|http://purl.obolibrary.org/obo/CHEBI_53092
T26 8508-8514 Chemical denotes serine http://purl.obolibrary.org/obo/CHEBI_17822
T27 9316-9323 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T28 10297-10311 Chemical denotes anticoagulants http://purl.obolibrary.org/obo/CHEBI_50249
T29 10909-10922 Chemical denotes anticoagulant http://purl.obolibrary.org/obo/CHEBI_50249
T30 11397-11400 Chemical denotes DIC http://purl.obolibrary.org/obo/CHEBI_4305|http://purl.obolibrary.org/obo/CHEBI_53092
T32 11549-11556 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T33 11758-11767 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T34 11880-11893 Chemical denotes anticoagulant http://purl.obolibrary.org/obo/CHEBI_50249
T35 12046-12053 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T36 12152-12160 Chemical denotes heparins http://purl.obolibrary.org/obo/CHEBI_24505
T37 12233-12240 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T38 12546-12554 Chemical denotes heparins http://purl.obolibrary.org/obo/CHEBI_24505
T39 12565-12579 Chemical denotes anticoagulants http://purl.obolibrary.org/obo/CHEBI_50249
T40 12622-12629 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T41 13027-13034 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T42 13088-13095 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T43 13141-13149 Chemical denotes heparins http://purl.obolibrary.org/obo/CHEBI_24505
T44 13377-13385 Chemical denotes heparins http://purl.obolibrary.org/obo/CHEBI_24505
T45 13459-13468 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T46 13493-13500 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T47 13519-13526 Chemical denotes mixture http://purl.obolibrary.org/obo/CHEBI_60004
T48 13530-13548 Chemical denotes glycosaminoglycans http://purl.obolibrary.org/obo/CHEBI_18085
T49 13588-13601 Chemical denotes anticoagulant http://purl.obolibrary.org/obo/CHEBI_50249
T50 13705-13722 Chemical denotes pathway inhibitor http://purl.obolibrary.org/obo/CHEBI_76932
T51 13713-13722 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T52 13938-13945 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T53 14054-14059 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T54 14363-14376 Chemical denotes anticoagulant http://purl.obolibrary.org/obo/CHEBI_50249
T55 14508-14518 Chemical denotes argatroban http://purl.obolibrary.org/obo/CHEBI_48720
T56 14520-14531 Chemical denotes bivalirudin http://purl.obolibrary.org/obo/CHEBI_59173
T57 14546-14560 Chemical denotes anticoagulants http://purl.obolibrary.org/obo/CHEBI_50249
T58 14637-14647 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T59 15074-15086 Chemical denotes nucleic acid http://purl.obolibrary.org/obo/CHEBI_33696
T60 15082-15086 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T61 17116-17118 Chemical denotes PE http://purl.obolibrary.org/obo/CHEBI_16038|http://purl.obolibrary.org/obo/CHEBI_17553|http://purl.obolibrary.org/obo/CHEBI_74762
T64 17193-17195 Chemical denotes PE http://purl.obolibrary.org/obo/CHEBI_16038|http://purl.obolibrary.org/obo/CHEBI_17553|http://purl.obolibrary.org/obo/CHEBI_74762
T67 17750-17760 Chemical denotes antivirals http://purl.obolibrary.org/obo/CHEBI_22587
T68 17782-17792 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T69 17911-17913 Chemical denotes PE http://purl.obolibrary.org/obo/CHEBI_16038|http://purl.obolibrary.org/obo/CHEBI_17553|http://purl.obolibrary.org/obo/CHEBI_74762
T72 19381-19385 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T73 19451-19455 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T74 19862-19866 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T75 19897-19901 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T76 19954-19958 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T77 20135-20139 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T78 20264-20270 Chemical denotes Oxygen http://purl.obolibrary.org/obo/CHEBI_15379
T79 20326-20332 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T80 20421-20427 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T81 20648-20654 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T82 20945-20956 Chemical denotes clopidogrel http://purl.obolibrary.org/obo/CHEBI_37941
T83 20958-20967 Chemical denotes prasugrel http://purl.obolibrary.org/obo/CHEBI_87715
T84 20969-20979 Chemical denotes ticagrelor http://purl.obolibrary.org/obo/CHEBI_68558
T85 20985-20995 Chemical denotes cilostazol http://purl.obolibrary.org/obo/CHEBI_31401
T86 21084-21112 Chemical denotes phosphodiesterase inhibitors http://purl.obolibrary.org/obo/CHEBI_50218
T87 21102-21112 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T88 21121-21133 Chemical denotes dipyridamole http://purl.obolibrary.org/obo/CHEBI_4653
T89 21272-21287 Chemical denotes pharmaceuticals http://purl.obolibrary.org/obo/CHEBI_52217
T90 21305-21310 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T91 22431-22444 Chemical denotes anticoagulant http://purl.obolibrary.org/obo/CHEBI_50249
T92 23437-23445 Chemical denotes heparins http://purl.obolibrary.org/obo/CHEBI_24505
T93 23456-23470 Chemical denotes anticoagulants http://purl.obolibrary.org/obo/CHEBI_50249
T94 23563-23571 Chemical denotes heparins http://purl.obolibrary.org/obo/CHEBI_24505
T95 23834-23838 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T96 23882-23886 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 22-30 Species denotes Patients Tax:9606
4 0-18 Disease denotes Viral Coagulopathy
5 36-44 Disease denotes COVID-19 MESH:C000657245
36 559-590 Gene denotes angiotensin-converting enzyme 2 Gene:59272
37 595-626 Gene denotes transmembrane protease serine 2 Gene:7113
38 1059-1067 Gene denotes thrombin Gene:2147
39 1670-1698 Gene denotes Tissue plasminogen activator Gene:100128998
40 160-170 Species denotes SARS-CoV-2 Tax:2697049
41 231-248 Species denotes novel coronavirus Tax:2697049
42 382-392 Species denotes SARS-CoV-2 Tax:2697049
43 489-499 Species denotes SARS-CoV-2 Tax:2697049
44 1255-1263 Species denotes patients Tax:9606
45 1421-1429 Species denotes patients Tax:9606
46 1660-1668 Species denotes patients Tax:9606
47 1826-1834 Species denotes patients Tax:9606
48 1331-1338 Chemical denotes heparin MESH:D006493
49 1343-1373 Chemical denotes low-molecular-weights heparins MESH:D006495
50 75-83 Disease denotes COVID-19 MESH:C000657245
51 700-708 Disease denotes COVID-19 MESH:C000657245
52 713-731 Disease denotes viral coagulopathy
53 746-764 Disease denotes pulmonary embolism MESH:D011655
54 802-812 Disease denotes thrombosis MESH:D013927
55 814-837 Disease denotes lung endothelial injury MESH:D055370
56 854-878 Disease denotes thrombotic complications MESH:D013927
57 890-925 Disease denotes acute respiratory distress syndrome MESH:D012128
58 927-945 Disease denotes Viral coagulopathy
59 1140-1179 Disease denotes intravascular coagulation–like syndrome MESH:D004211
60 1218-1242 Disease denotes thrombotic complications MESH:D013927
61 1246-1254 Disease denotes COVID-19 MESH:C000657245
62 1412-1420 Disease denotes COVID-19 MESH:C000657245
63 1846-1864 Disease denotes pulmonary embolism MESH:D011655
64 1986-1994 Disease denotes COVID-19 MESH:C000657245
65 2006-2030 Disease denotes thrombotic complications MESH:D013927
67 2078-2086 Disease denotes COVID-19 MESH:C000657245
78 2785-2816 Gene denotes angiotensin-converting enzyme-2 Gene:59272
79 2818-2823 Gene denotes ACE-2 Gene:59272
80 2837-2868 Gene denotes transmembrane protease serine 2 Gene:7113
81 2870-2877 Gene denotes TMPRSS2 Gene:7113
82 2555-2563 Species denotes patients Tax:9606
83 3007-3025 Chemical denotes hydroxychloroquine MESH:D006886
84 2579-2587 Disease denotes COVID-19 MESH:C000657245
85 3134-3169 Disease denotes acute respiratory distress syndrome MESH:D012128
86 3171-3175 Disease denotes ARDS MESH:D012128
87 3182-3193 Disease denotes pneumonitis MESH:D011014
93 3248-3256 Species denotes patients Tax:9606
94 3419-3427 Species denotes patients Tax:9606
95 3239-3247 Disease denotes COVID-19 MESH:C000657245
96 3301-3319 Disease denotes viral coagulopathy
97 3410-3418 Disease denotes COVID-19 MESH:C000657245
100 3639-3659 Disease denotes SARS-CoV-2 Infection MESH:C000657245
101 3661-3669 Disease denotes COVID-19 MESH:C000657245
105 3983-3988 Gene denotes ACE-2 Gene:59272
106 3993-4000 Gene denotes TMPRSS2 Gene:7113
107 3671-3679 Disease denotes COVID-19 MESH:C000657245
121 4036-4041 Gene denotes ACE-2 Gene:59272
122 4245-4250 Gene denotes ACE-2 Gene:59272
123 4502-4509 Gene denotes TMPRSS2 Gene:7113
124 4191-4196 Species denotes human Tax:9606
125 4265-4270 Species denotes human Tax:9606
126 4429-4434 Species denotes human Tax:9606
127 4623-4633 Species denotes SARS-CoV-2 Tax:2697049
128 4912-4922 Species denotes SARS-CoV-2 Tax:2697049
129 5079-5087 Species denotes patients Tax:9606
130 4376-4395 Disease denotes infectious reaction MESH:D003141
131 4661-4669 Disease denotes COVID-19 MESH:C000657245
132 4838-4842 Disease denotes ARDS MESH:D012128
133 5070-5078 Disease denotes COVID-19 MESH:C000657245
136 5174-5182 Disease denotes COVID-19 MESH:C000657245
137 5194-5212 Disease denotes Viral Coagulopathy
153 5722-5730 Species denotes patients Tax:9606
154 5852-5860 Species denotes SARS-CoV Tax:694009
155 6055-6063 Species denotes SARS-CoV Tax:694009
156 5222-5230 Disease denotes COVID-19 MESH:C000657245
157 5287-5295 Disease denotes COVID-19 MESH:C000657245
158 5420-5428 Disease denotes COVID-19 MESH:C000657245
159 5469-5487 Disease denotes pulmonary embolism MESH:D011655
160 5535-5545 Disease denotes thrombosis MESH:D013927
161 5579-5591 Disease denotes viral injury
162 5736-5744 Disease denotes COVID-19 MESH:C000657245
163 5748-5764 Disease denotes Viral infections MESH:D001102
164 5881-5909 Disease denotes viral respiratory infections
165 5938-5959 Disease denotes intravascular thrombi MESH:D004211
166 5998-6016 Disease denotes Pulmonary infarcts MESH:D054060
167 6021-6037 Disease denotes thrombocytopenia MESH:D013921
197 6117-6125 Species denotes patients Tax:9606
198 6131-6135 Species denotes H1N1 Tax:114727
199 6220-6224 Species denotes H1N1 Tax:114727
200 6253-6258 Species denotes swine Tax:9823
201 6363-6373 Species denotes SARS-CoV-2 Tax:2697049
202 6375-6388 Species denotes Coronaviridae Tax:11118
203 6583-6587 Species denotes H1N1 Tax:114727
204 6939-6943 Species denotes H1N1 Tax:114727
205 6977-6985 Species denotes patients Tax:9606
206 7079-7083 Species denotes H1N1 Tax:114727
207 7176-7184 Species denotes Patients Tax:9606
208 6137-6141 Disease denotes ARDS MESH:D012128
209 6178-6209 Disease denotes venous thrombotic complications MESH:D013927
210 6465-6480 Disease denotes viral pneumonia
211 6496-6514 Disease denotes viral coagulopathy
212 6606-6627 Disease denotes alveolar septal edema MESH:D004487
213 6629-6663 Disease denotes hyperplasia of type II pneumocytes MESH:D006965
214 6672-6680 Disease denotes thrombus MESH:D013927
215 6704-6712 Disease denotes necrosis MESH:D009336
216 6747-6762 Disease denotes alveolar damage MESH:D055370
217 6779-6789 Disease denotes hemorrhage MESH:D006470
218 6791-6816 Disease denotes necrotizing bronchiolitis MESH:D001988
219 6832-6842 Disease denotes thrombosis MESH:D013927
220 6996-7015 Disease denotes thrombotic vascular MESH:D013927
221 7038-7076 Disease denotes venous circulation or arterial thrombi MESH:D020243
222 7084-7094 Disease denotes thrombotic MESH:D013927
223 7165-7174 Disease denotes mortality MESH:D003643
224 7199-7206 Disease denotes thrombi MESH:D013927
225 7277-7284 Disease denotes thrombi MESH:D013927
236 7610-7618 Species denotes patients Tax:9606
237 7792-7802 Species denotes SARS-CoV-2 Tax:2697049
238 7914-7922 Species denotes patients Tax:9606
239 7360-7369 Disease denotes infection MESH:D007239
240 7471-7529 Disease denotes disseminated intravascular coagulation (DIC)–like syndrome MESH:D004211
241 7581-7597 Disease denotes thrombocytopenia MESH:D013921
242 7601-7609 Disease denotes COVID-19 MESH:C000657245
243 7687-7702 Disease denotes viral infection MESH:D001102
244 7881-7897 Disease denotes thrombocytopenia MESH:D013921
245 7938-7954 Disease denotes thrombocytopenia MESH:D013921
260 8069-8080 Species denotes coronavirus Tax:11118
261 8584-8592 Species denotes patients Tax:9606
262 8820-8828 Species denotes patients Tax:9606
263 8508-8514 Chemical denotes serine MESH:D012694
264 8092-8102 Disease denotes infections MESH:D007239
265 8184-8192 Disease denotes bleeding MESH:D006470
266 8197-8221 Disease denotes thrombotic complications MESH:D013927
267 8227-8243 Disease denotes viral infections MESH:D001102
268 8596-8612 Disease denotes Viral infections MESH:D001102
269 8774-8784 Disease denotes thrombotic MESH:D013927
270 8811-8819 Disease denotes COVID-19 MESH:C000657245
271 8965-8973 Disease denotes COVID-19 MESH:C000657245
272 8985-8993 Disease denotes bleeding MESH:D006470
273 8998-9018 Disease denotes thrombotic disorders MESH:D013927
293 9484-9494 Gene denotes fibrinogen Gene:2244
294 10118-10128 Gene denotes fibrinogen Gene:2244
295 9229-9237 Species denotes patients Tax:9606
296 9591-9599 Species denotes patients Tax:9606
297 9724-9732 Species denotes patients Tax:9606
298 9816-9824 Species denotes patients Tax:9606
299 10107-10115 Species denotes patients Tax:9606
300 10192-10200 Species denotes patients Tax:9606
301 9316-9323 Chemical denotes heparin MESH:D006493
302 9325-9329 Chemical denotes LMWH MESH:D006495
303 9124-9134 Disease denotes Thrombosis MESH:D013927
304 9204-9216 Disease denotes coagulopathy MESH:D001778
305 9220-9228 Disease denotes COVID-19 MESH:C000657245
306 9354-9362 Disease denotes bleeding MESH:D006470
307 9578-9587 Disease denotes mortality MESH:D003643
308 9612-9620 Disease denotes COVID-19 MESH:C000657245
309 9715-9723 Disease denotes COVID-19 MESH:C000657245
310 9801-9815 Disease denotes critically ill MESH:D016638
311 9952-9960 Disease denotes bleeding MESH:D006470
320 10504-10526 Disease denotes venous thromboembolism MESH:D054556
321 10528-10531 Disease denotes VTE MESH:D054556
322 10549-10557 Disease denotes COVID-19 MESH:C000657245
323 10558-10567 Disease denotes infection MESH:D007239
324 10763-10771 Disease denotes COVID-19 MESH:C000657245
325 10783-10786 Disease denotes VTE MESH:D054556
326 10866-10869 Disease denotes VTE MESH:D054556
327 11152-11160 Disease denotes COVID-19 MESH:C000657245
332 11280-11288 Species denotes patients Tax:9606
333 11247-11264 Disease denotes venous thrombosis MESH:D020246
334 11271-11279 Disease denotes COVID-19 MESH:C000657245
335 11416-11432 Disease denotes critical illness MESH:D016638
358 11618-11626 Species denotes patients Tax:9606
359 11917-11925 Species denotes patients Tax:9606
360 12119-12127 Species denotes patients Tax:9606
361 12597-12605 Species denotes patients Tax:9606
362 11549-11556 Chemical denotes heparin MESH:D006493
363 11558-11561 Chemical denotes UFH MESH:D006493
364 11567-11571 Chemical denotes LMWH MESH:D006495
365 11832-11835 Chemical denotes UFH MESH:D006493
366 12046-12053 Chemical denotes heparin MESH:D006493
367 12062-12072 Chemical denotes enoxaparin MESH:D017984
368 12131-12160 Chemical denotes Low-molecular-weight heparins MESH:D006495
369 12233-12240 Chemical denotes heparin MESH:D006493
370 12326-12329 Chemical denotes UFH MESH:D006493
371 12359-12362 Chemical denotes UFH MESH:D006493
372 12367-12371 Chemical denotes LMWH MESH:D006495
373 12546-12554 Chemical denotes heparins MESH:D006493
374 11609-11617 Disease denotes COVID-19 MESH:C000657245
375 11908-11916 Disease denotes COVID-19 MESH:C000657245
376 12110-12118 Disease denotes COVID-19 MESH:C000657245
377 12279-12287 Disease denotes bleeding MESH:D006470
378 12292-12308 Disease denotes thrombocytopenia MESH:D013921
379 12588-12596 Disease denotes COVID-19 MESH:C000657245
397 12988-12996 Species denotes patients Tax:9606
398 12622-12629 Chemical denotes heparin MESH:D006493
399 12767-12770 Chemical denotes UFH MESH:D006493
400 12866-12869 Chemical denotes UFH MESH:D006493
401 13027-13034 Chemical denotes heparin MESH:D006493
402 13088-13095 Chemical denotes heparin MESH:D006493
403 13141-13149 Chemical denotes heparins MESH:D006493
404 13377-13385 Chemical denotes heparins MESH:D006493
405 12812-12823 Disease denotes lung injury MESH:D055370
406 12943-12952 Disease denotes pneumonia MESH:D011014
407 13044-13055 Disease denotes lung injury MESH:D055370
408 13189-13226 Disease denotes chronic obstructive pulmonary disease MESH:D029424
409 13237-13250 Disease denotes lung diseases MESH:D008171
410 13259-13276 Disease denotes inhalation injury MESH:D015208
411 13290-13298 Disease denotes COVID-19 MESH:C000657245
412 13299-13314 Disease denotes viral infection MESH:D001102
413 13338-13354 Disease denotes pulmonary injury MESH:D055370
422 13691-13722 Gene denotes tissue factor pathway inhibitor Gene:7035
423 13724-13728 Gene denotes TFPI Gene:7035
424 13493-13500 Chemical denotes heparin MESH:D006493
425 13530-13548 Chemical denotes glycosaminoglycans MESH:D006025
426 13908-13912 Chemical denotes LMWH MESH:D006495
427 13938-13945 Chemical denotes heparin MESH:D006493
428 14013-14016 Chemical denotes UFH MESH:D006493
429 14215-14218 Chemical denotes UFH MESH:D006493
452 14619-14628 Gene denotes factor Xa Gene:2159
453 15252-15280 Gene denotes Tissue plasminogen activator Gene:100128998
454 14487-14499 Gene denotes antithrombin Gene:462
455 15282-15285 Gene denotes tPA Gene:100128998
456 14448-14456 Species denotes patients Tax:9606
457 14727-14734 Species denotes patient Tax:9606
458 14857-14864 Species denotes patient Tax:9606
459 15014-15022 Species denotes patients Tax:9606
460 15334-15342 Species denotes patients Tax:9606
461 14508-14518 Chemical denotes argatroban MESH:C031942
462 14562-14567 Chemical denotes DOACs
463 14570-14580 Chemical denotes danaparoid MESH:C035838
464 14586-14596 Chemical denotes sulodexide MESH:C007858
465 14602-14607 Chemical denotes DOACs
466 14891-14901 Chemical denotes danaparoid MESH:C035838
467 14906-14916 Chemical denotes sulodexide MESH:C007858
468 15059-15070 Chemical denotes Defibrotide MESH:C036901
469 14439-14447 Disease denotes COVID-19 MESH:C000657245
470 15005-15013 Disease denotes COVID-19 MESH:C000657245
471 15305-15313 Disease denotes COVID-19 MESH:C000657245
472 15325-15329 Disease denotes ARDS MESH:D012128
473 15348-15392 Disease denotes refractory microthromboembolic complications MESH:D000069279
480 15487-15495 Species denotes patients Tax:9606
481 15562-15570 Species denotes patients Tax:9606
482 15735-15742 Species denotes patient Tax:9606
483 15606-15628 Disease denotes bleeding complications MESH:D006470
484 15764-15772 Disease denotes bleeding MESH:D006470
485 15784-15799 Disease denotes ischemic stroke MESH:D002544
498 16166-16170 Species denotes calf Tax:9913
499 16360-16367 Species denotes patient Tax:9606
500 16662-16666 Species denotes calf Tax:9913
501 16745-16749 Species denotes calf Tax:9913
502 16998-17006 Species denotes patients Tax:9606
503 16016-16063 Disease denotes endothelial injury, prothrombotic blood factors MESH:D020147
504 16278-16291 Disease denotes venous stasis MESH:D054070
505 16328-16340 Disease denotes nonparalyzed
506 16576-16586 Disease denotes thrombosis MESH:D013927
507 16979-16982 Disease denotes VTE MESH:D054556
508 17007-17015 Disease denotes infected MESH:D007239
509 17021-17029 Disease denotes COVID-19 MESH:C000657245
511 17050-17062 Disease denotes Thrombolysis
517 17768-17781 Gene denotes interleukin 6 Gene:3569
518 17131-17139 Species denotes patients Tax:9606
519 17208-17216 Species denotes patients Tax:9606
520 17122-17130 Disease denotes COVID-19 MESH:C000657245
521 17199-17207 Disease denotes COVID-19 MESH:C000657245
525 18054-18062 Species denotes patients Tax:9606
526 18280-18288 Species denotes patients Tax:9606
527 18068-18076 Disease denotes COVID-19 MESH:C000657245
535 18648-18656 Species denotes patients Tax:9606
536 18679-18687 Species denotes patients Tax:9606
537 19161-19169 Species denotes patients Tax:9606
538 19328-19336 Species denotes patients Tax:9606
539 18670-18678 Disease denotes COVID-19 MESH:C000657245
540 19079-19087 Disease denotes COVID-19 MESH:C000657245
541 19319-19327 Disease denotes COVID-19 MESH:C000657245
544 19512-19547 Disease denotes Acute respiratory distress syndrome MESH:D012128
545 20126-20134 Disease denotes COVID-19 MESH:C000657245
547 20264-20270 Chemical denotes Oxygen MESH:D010100
559 20394-20402 Species denotes patients Tax:9606
560 20584-20592 Species denotes patients Tax:9606
561 20714-20722 Species denotes patients Tax:9606
562 20326-20332 Chemical denotes oxygen MESH:D010100
563 20421-20427 Chemical denotes oxygen MESH:D010100
564 20648-20654 Chemical denotes oxygen MESH:D010100
565 20374-20381 Disease denotes hypoxia MESH:D000860
566 20385-20393 Disease denotes COVID-19 MESH:C000657245
567 20560-20574 Disease denotes critically ill MESH:D016638
568 20575-20583 Disease denotes COVID-19 MESH:C000657245
569 20695-20713 Disease denotes COVID-19 pneumonia MESH:C000657245
583 20849-20857 Species denotes patients Tax:9606
584 21002-21012 Species denotes SARS-CoV-2 Tax:2697049
585 21151-21159 Species denotes patients Tax:9606
586 20945-20956 Chemical denotes clopidogrel MESH:D000077144
587 20958-20967 Chemical denotes prasugrel MESH:D000068799
588 20969-20979 Chemical denotes ticagrelor MESH:D000077486
589 20985-20995 Chemical denotes cilostazol MESH:D000077407
590 21121-21133 Chemical denotes dipyridamole MESH:D004176
591 20840-20848 Disease denotes COVID-19 MESH:C000657245
592 20863-20886 Disease denotes coronary artery disease MESH:D003324
593 20888-20891 Disease denotes CAD
594 21178-21186 Disease denotes COVID 19 MESH:C000657245
595 21331-21339 Disease denotes COVID-19 MESH:C000657245
597 21358-21370 Disease denotes Heart Injury MESH:D006335
603 21431-21439 Species denotes patients Tax:9606
604 21422-21430 Disease denotes COVID-19 MESH:C000657245
605 21451-21463 Disease denotes heart injury MESH:D006335
606 21546-21558 Disease denotes heart injury MESH:D006335
607 21774-21786 Disease denotes heart injury MESH:D006335
615 22299-22302 Gene denotes PCI Gene:5104
616 22218-22221 Gene denotes tPA Gene:100128998
617 21793-21803 Species denotes SARS-CoV-2 Tax:2697049
618 21848-21860 Disease denotes heart injury MESH:D006335
619 22114-22131 Disease denotes coronary syndrome MESH:D054058
620 22150-22153 Disease denotes CAD
621 22258-22280 Disease denotes cardiovascular disease MESH:D002318
623 22466-22472 Disease denotes Stroke MESH:D020521
629 22673-22676 Gene denotes tPA Gene:100128998
630 22544-22552 Species denotes patients Tax:9606
631 22802-22810 Species denotes patients Tax:9606
632 22525-22532 Disease denotes strokes MESH:D020521
633 22558-22566 Disease denotes COVID-19 MESH:C000657245
639 22869-22877 Disease denotes COVID-19 MESH:C000657245
640 23039-23047 Disease denotes COVID-19 MESH:C000657245
641 23162-23170 Disease denotes COVID-19 MESH:C000657245
642 23218-23226 Disease denotes COVID-19 MESH:C000657245
643 23285-23293 Disease denotes COVID-19 MESH:C000657245
649 23704-23712 Species denotes Patients Tax:9606
650 23437-23445 Chemical denotes heparins MESH:D006493
651 23563-23571 Chemical denotes heparins MESH:D006493
652 23805-23817 Disease denotes heart injury MESH:D006335
653 23873-23881 Disease denotes COVID-19 MESH:C000657245
655 24638-24646 Disease denotes ORCID iD MESH:C535742

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 144-156 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T2 1090-1101 http://purl.obolibrary.org/obo/GO_0009056 denotes degradation
T3 1154-1165 http://purl.obolibrary.org/obo/GO_0050817 denotes coagulation
T4 1677-1698 http://purl.obolibrary.org/obo/GO_0031639 denotes plasminogen activator
T5 1970-1982 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T6 3623-3635 http://purl.obolibrary.org/obo/GO_0009405 denotes Pathogenesis
T7 4634-4646 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T8 4745-4768 http://purl.obolibrary.org/obo/GO_0045766 denotes stimulates angiogenesis
T9 4756-4768 http://purl.obolibrary.org/obo/GO_0001525 denotes angiogenesis
T10 4795-4817 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory responses
T11 4945-4957 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T12 5748-5764 http://purl.obolibrary.org/obo/GO_0016032 denotes Viral infections
T13 5830-5841 http://purl.obolibrary.org/obo/GO_0050817 denotes coagulation
T14 6704-6712 http://purl.obolibrary.org/obo/GO_0070265 denotes necrosis
T15 6704-6712 http://purl.obolibrary.org/obo/GO_0019835 denotes necrosis
T16 6704-6712 http://purl.obolibrary.org/obo/GO_0008219 denotes necrosis
T17 6704-6712 http://purl.obolibrary.org/obo/GO_0001906 denotes necrosis
T18 7498-7509 http://purl.obolibrary.org/obo/GO_0050817 denotes coagulation
T19 7669-7679 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T20 7687-7702 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T21 7776-7788 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T22 8127-8139 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T23 8227-8243 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T24 8380-8391 http://purl.obolibrary.org/obo/GO_0050817 denotes coagulation
T25 8596-8612 http://purl.obolibrary.org/obo/GO_0016032 denotes Viral infections
T26 8903-8915 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T27 9139-9149 http://purl.obolibrary.org/obo/GO_0007599 denotes Hemostasis
T28 11124-11136 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T29 11513-11524 http://purl.obolibrary.org/obo/GO_0050817 denotes coagulation
T30 13299-13314 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T31 13837-13843 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T32 15259-15280 http://purl.obolibrary.org/obo/GO_0031639 denotes plasminogen activator
T33 18824-18836 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T34 21013-21025 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T35 21084-21112 http://purl.obolibrary.org/obo/GO_0051344 denotes phosphodiesterase inhibitors
T36 23255-23281 http://purl.obolibrary.org/obo/GO_0030324 denotes lungs, and the development

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-45 Sentence denotes Viral Coagulopathy in Patients With COVID-19:
T2 46-64 Sentence denotes Treatment and Care
T3 66-74 Sentence denotes Abstract
T4 75-171 Sentence denotes COVID-19 has proven to be particularly challenging given the complex pathogenesis of SARS-CoV-2.
T5 172-375 Sentence denotes Early data have demonstrated how the host response to this novel coronavirus leads to the proliferation of pro-inflammatory cytokines, massive endothelial damage, and generalized vascular manifestations.
T6 376-488 Sentence denotes While SARS-CoV-2 primarily targets the upper and lower respiratory tract, other organ systems are also affected.
T7 489-627 Sentence denotes SARS-CoV-2 relies on 2 host cell receptors for successful attachment: angiotensin-converting enzyme 2 and transmembrane protease serine 2.
T8 628-926 Sentence denotes Clinicopathologic reports have demonstrated associations between severe COVID-19 and viral coagulopathy, resulting in pulmonary embolism; venous, arterial, and microvascular thrombosis; lung endothelial injury; and associated thrombotic complications leading to acute respiratory distress syndrome.
T9 927-1180 Sentence denotes Viral coagulopathy is not novel given similar observations with SARS classic, including the consumption of platelets, generation of thrombin, and increased fibrin degradation product exhibiting overt disseminated intravascular coagulation–like syndrome.
T10 1181-1295 Sentence denotes The specific mechanism(s) behind the thrombotic complications in COVID-19 patients has yet to be fully understood.
T11 1296-1430 Sentence denotes Parenteral anticoagulants, such as heparin and low-molecular-weights heparins, are widely used in the management of COVID-19 patients.
T12 1431-1565 Sentence denotes Beyond the primary (anticoagulant) effects of these agents, they may exhibit antiviral, anti-inflammatory, and cytoprotective effects.
T13 1566-1669 Sentence denotes Direct oral anticoagulants and antiplatelet agents are also useful in the management of these patients.
T14 1670-1779 Sentence denotes Tissue plasminogen activator and other fibrinolytic modalities may also be helpful in the overall management.
T15 1780-1865 Sentence denotes Catheter-directed thrombolysis can be used in patients developing pulmonary embolism.
T16 1866-2031 Sentence denotes Further investigations are required to understand the molecular and cellular mechanisms involved in the pathogenesis of COVID-19-associated thrombotic complications.
T17 2033-2045 Sentence denotes Introduction
T18 2046-2191 Sentence denotes There are more than 3.8 million COVID-19 cases identified globally, and the race to develop possible vaccines is more important than ever before.
T19 2192-2304 Sentence denotes However, it will be some time before a vaccine candidate(s) has been evaluated in well-designed clinical trials.
T20 2305-2501 Sentence denotes More importantly, immunization would only protect against the spread of new cases, whereas treatment options for current and future cases are limited to supportive care and experimental therapies.
T21 2502-3027 Sentence denotes Early reports on the clinical course of hospitalized patients suffering from COVID-19 indicate the empiric utilization of various pharmacologic treatments.1,2 These treatments include antivirals that may block viral binding (eg, monoclonal antibodies, Angiotensin Receptor Blockers, angiotensin-converting enzyme-2 [ACE-2] inhibitors, transmembrane protease serine 2 [TMPRSS2] inhibitors), inhibit viral RNA production (ie, direct antiviral agents), or inhibit the release of mature virion particles (eg, hydroxychloroquine).
T22 3028-3194 Sentence denotes Other treatments include immunosuppressants aimed at mitigating the autoimmune-type reactions involved in acute respiratory distress syndrome (ARDS) with pneumonitis.
T23 3195-3320 Sentence denotes Recently, studies of the clinical course of COVID-19 patients have demonstrated a concerning incidence of viral coagulopathy.
T24 3321-3501 Sentence denotes The aim of this article is to provide an updated review on the coagulopathies present in COVID-19 patients with reference to their impact on molecular, cellular, and organ targets.
T25 3502-3621 Sentence denotes Additionally, the current approaches in the anticoagulant management and other supportive therapies are also addressed.
T26 3623-3670 Sentence denotes Pathogenesis of SARS-CoV-2 Infection (COVID-19)
T27 3671-3881 Sentence denotes COVID-19 appears to mainly affect the upper and lower respiratory tract, though newer reports also implicate other organ systems (ie, cardiovascular, digestive, renal, and nervous systems) in certain subgroups.
T28 3882-4002 Sentence denotes It has been demonstrated that the virus may rely on 2 host cell receptors for successful attachment, ACE-2 and TMPRSS2.3
T29 4003-4660 Sentence denotes Previous studies have shown that ACE-2 is highly expressed in the endothelial cells of arteries and veins, arterial smooth muscle cells, and type I and type II alveolar epithelia cells in human lung tissue.4 Despite the large distribution of ACE-2 expression in human tissues, preliminary analysis of clinical specimens indicates that there is little evidence for profound infectious reaction at a systemic level.5 Similarly, human tissue specimen analysis of TMRPSS2 has revealed the expression of TMPRSS2 in lung tissue.6 Therefore, the convergent distribution of these 2 factors in the respiratory system may explain SARS-CoV-2 pathogenesis in the lungs.
T30 4661-5011 Sentence denotes COVID-19 targets pulmonary endothelial lining and, besides the receptor remodeling, stimulates angiogenesis and upregulates localized inflammatory responses resulting in severe ARDS.7,8 It is likely that other target organs may also be infiltrated by SARS-CoV-2 and exhibit localized pathogenesis as gastrointestinal tract, kidneys, heart, and brain.
T31 5012-5172 Sentence denotes A recent study reporting on the postmortem examination of COVID-19 patients also suggested the involvement of multiple organs including central nervous system.9
T32 5174-5212 Sentence denotes COVID-19-Associated Viral Coagulopathy
T33 5213-5346 Sentence denotes Although COVID-19-associated illness mainly presents itself in the lungs, COVID-19 has been shown to manifest in other organ systems.
T34 5347-5612 Sentence denotes Recent clinical and pathological data demonstrate an association between COVID-19 and coagulopathies that may manifest as pulmonary embolism (PE) or venous, arterial, and/or microvascular thrombosis which are associated with severe viral injury of lung endothelium.
T35 5613-5851 Sentence denotes In light of these findings, several professional groups have recommended anticoagulation in all hospitalized patients with COVID-19.10 Viral infections may cause prothrombotic states through the modulation of various coagulation proteins.
T36 5852-6077 Sentence denotes SARS-CoV-1 and several other viral respiratory infections have demonstrated increased intravascular thrombi and fibrin deposition in the lungs.11 Pulmonary infarcts and thrombocytopenia were observed in SARS-CoV-1 cases.11,12
T37 6078-6210 Sentence denotes It was previously demonstrated that in patients with H1N1, ARDS had significantly increased risk of venous thrombotic complications.
T38 6211-6515 Sentence denotes The 2009 H1N1 pandemic (pH1N1/09 virus or swine flu) was estimated to have claimed as many as 575 000 lives.13 Although pH1N1/09 (Orthomyxoviridae) and SARS-CoV-2 (Coronaviridae) originate from different viral families, both are highly pathogenic, cause viral pneumonia, and exhibited viral coagulopathy.
T39 6516-7078 Sentence denotes Several postmortem, retrospective, pathological studies during the H1N1 pandemic revealed alveolar septal edema, hyperplasia of type II pneumocytes, fibrin thrombus in the vascular lumen, necrosis of the bronchiolar walls, diffuse alveolar damage, intra-alveolar hemorrhage, necrotizing bronchiolitis, microthrombi, thrombosis of the large pulmonary arteries, and hemophagocytosis.14–18 A retrospective cohort study on 119 H1N1 cases revealed that almost 6% of patients developed thrombotic vascular events (either in the venous circulation or arterial thrombi).
T40 7079-7175 Sentence denotes H1N1 thrombotic events were associated with an increased length of stay and increased mortality.
T41 7176-7287 Sentence denotes Patients who developed thrombi had no underlying conditions that would predispose them to developing thrombi.19
T42 7288-7619 Sentence denotes SARS-induced platelet depletion was believed to be caused by the direct infection of the hemopoietic stem/progenitor cells and megakaryocytes.12 Consumption of platelets due to overt disseminated intravascular coagulation (DIC)–like syndrome may also be a contributing factor for the observed thrombocytopenia in COVID-19 patients.
T43 7620-7767 Sentence denotes Additionally, platelet sequestration and splenic regulation due to viral infection should be explored for potential involvement in these processes.
T44 7768-7923 Sentence denotes Similar pathogenesis in SARS-CoV-2 has yet to be determined; however, clinical course follow-up has demonstrated thrombocytopenia in hospitalized patients.
T45 7924-8028 Sentence denotes Specifically, thrombocytopenia was more prominent in nonsurvivors (20%) versus survivors in one study.20
T46 8029-8325 Sentence denotes The extent of coagulopathies in various coronavirus-associated infections widely vary in terms of pathogenesis and severity outcomes.21 The association of bleeding and thrombotic complications with viral infections has been investigated extensively, and the mechanism involved is well understood.
T47 8326-8463 Sentence denotes These mechanisms include multiple processes involving coagulation and fibrinolytic network, platelets, endothelial cells, and leukocytes.
T48 8464-8689 Sentence denotes Fibrinolytic dysregulation and imbalance of serine proteases are also contributory to the fibrinolytic deficit in these patients.22 Viral infections has also been associated with the generation of antiphospholipid antibodies.
T49 8690-9019 Sentence denotes Recent publication has reported the association of antiphospholipid antibodies with thrombotic complications observed in COVID-19 patients.23 It is likely that certain additional mechanisms also contribute to the pathogenesis of vascular and hemostatic imbalance observed in COVID-19-associated bleeding and thrombotic disorders.
T50 9020-9094 Sentence denotes Additional investigations are needed to further elucidate these processes.
T51 9095-9238 Sentence denotes The International Society on Thrombosis and Hemostasis (ISTH) released interim guidance on the management of coagulopathy in COVID-19 patients.
T52 9239-9398 Sentence denotes The ISTH advises for the use of prophylactic doses of a low-molecular-weight heparin (LMWH) unless there is active bleeding or a platelet count of <25 × 109/L.
T53 9399-9942 Sentence denotes Additionally, periodic monitoring of d-dimer, prothrombin time, platelet counts, and fibrinogen levels are recommended.10 Reportedly, high d-dimer levels appear to correlate with mortality in patients with severe COVID-19; however, currently, it is not defined if this correlation is specific and/or significant for COVID-19 patients; hence, previously, a similar relationship has been demonstrated in critically ill patients.24 Moreover, elevated d-dimer cannot be envisioned as a guide for initiation and dose escalation for anticoagulation.
T54 9943-10183 Sentence denotes Although bleeding is rare, in instances where it is present, the ISTH panel advises on maintaining platelet counts >50 × 109/L (and >20 × 109/L goal in nonbleeding patients), fibrinogen >2.0 g/L, and the international normalized ratio <1.5.
T55 10184-10264 Sentence denotes In many patients, these measures may prove inadequate to predict coagulopathies.
T56 10265-10385 Sentence denotes In these cases, higher doses of anticoagulants and/or the incorporation of nonpharmacologic approaches may be warranted.
T57 10386-10568 Sentence denotes Currently, several other groups are developing consensus statement and guidelines for the prevention and treatment of venous thromboembolism (VTE) associated with COVID-19 infection.
T58 10569-10802 Sentence denotes A preguideline consensus statement is recently published on behalf of various international investigators.25 This statement provides practical recommendations for the diagnosis and treatment of COVID-19-associated VTE for clinicians.
T59 10803-10936 Sentence denotes Additionally, in this document, risk assessment, prevention of VTE in various risk groups, and the use of anticoagulant are detailed.
T60 10937-11046 Sentence denotes It is expected that several other guidelines on behalf of various groups will also be introduced in due time.
T61 11047-11178 Sentence denotes Periodic update for these guidelines may be needed as additional data on the pathogenesis and outcome on COVID-19 become available.
T62 11179-11319 Sentence denotes The specific mechanism(s) accounting for the increased incidence of venous thrombosis among COVID-19 patients has not been fully elucidated.
T63 11320-11433 Sentence denotes This heightened risk may be just part of the series of events that led up to DIC typical of any critical illness.
T64 11434-11533 Sentence denotes Alternatively, there may be a direct effect of the virus on the endothelium or coagulation cascade.
T65 11534-11926 Sentence denotes Unfractionated heparin (UFH) and LMWH are widely used in the management of COVID-19 patients.26–29 Besides possessing anticoagulation and antithrombotic properties, these agents produce other pharmacologic effects including antiviral, anti-inflammatory, and cytoprotective effects.30–33 Parenteral UFH at therapeutic dosage has been used for the anticoagulant management of COVID-19 patients.
T66 11927-12024 Sentence denotes Individual dosage adjustment to achieve therapeutic anticoagulation requires frequent monitoring.
T67 12025-12211 Sentence denotes Low-molecular-weight heparin such as enoxaparin at 40 mg or higher is widely used in COVID-19 patients.34 Low-molecular-weight heparins are now widely used and do not require monitoring.
T68 12212-12330 Sentence denotes Low-molecular-weight heparin also have a lower potential to induce bleeding and thrombocytopenia in comparison to UFH.
T69 12331-12478 Sentence denotes The current use of both the UFH and LMWH is empirical and will require clear recommendations based on the outcomes observed in the ongoing studies.
T70 12479-12606 Sentence denotes Harmonized guidelines need to be developed for the use of not only heparins but other anticoagulants used in COVID-19 patients.
T71 12607-12997 Sentence denotes Unfractionated heparin has been used for intrapulmonary administration by several investigators utilizing different approaches.35–37 A pilot study of nebulized UFH for the prevention of ventilator-induced lung injury has been reported.38 Inhaled prophylactic UFH has also been shown to be effective for the prevention and management of pneumonia and ventilated intensive care unit patients.
T72 12998-13477 Sentence denotes A phase 1 trial of nebulized heparin in acute lung injury demonstrated better outcomes in heparin-treated groups.39 Other reports on nebulized heparins have demonstrated improved outcomes in chronic obstructive pulmonary disease and other lung diseases such as inhalation injury.40–42 As the COVID-19 viral infection results in significant pulmonary injury, the inhaled forms of heparins that reach lung tissue may be effective in through anti-inflammatory and antiviral effects.
T73 13478-13610 Sentence denotes Unfractionated heparin is a heterogenous mixture of glycosaminoglycans, and only 30% of its component produce anticoagulant effects.
T74 13611-14007 Sentence denotes The other 70% have multiple pharmacological properties including the release of tissue factor pathway inhibitor (TFPI) from the endothelium, direct interactions with vascular surface, cytoprotective effects, interactions with growth factors, and modulation of cellular regulatory processes.29 The LMWH represents depolymerized heparin derivatives with molecular weight in the range of 4 to 6 kDa.
T75 14008-14116 Sentence denotes Like UFH, only 30% of the components of these drugs interact with AT to produce their pharmacologic effects.
T76 14117-14200 Sentence denotes The LMWHs have a much longer biologic half-life and produce lesser adverse effects.
T77 14201-14329 Sentence denotes Comparable to UFH, these agents also exhibit anti-inflammatory effects and are capable of downregulating inflammatory cytokines.
T78 14330-14457 Sentence denotes There are several other types of anticoagulant and antithrombotic agents worthy of clinical investigation in COVID-19 patients.
T79 14458-14597 Sentence denotes This includes the parenteral antithrombin agents (argatroban, bivalirudin), direct oral anticoagulants (DOACs), danaparoid, and sulodexide.
T80 14598-14717 Sentence denotes The DOACs, including factor Xa and IIa inhibitors, may provide advantages including their oral route of administration.
T81 14718-14876 Sentence denotes However, patient risk stratification, bioavailability at specific sites of action, and onset of action needed to be studied in this unique patient population.
T82 14877-15058 Sentence denotes Likewise, for danaparoid and sulodexide, the determination of optimal dosage, duration of therapy, and monitoring parameters in COVID-19 patients require much further investigation.
T83 15059-15251 Sentence denotes Defibrotide, a nucleic acid–derived antithrombotic agent with additional pharmacological effects, is currently undergoing clinical trials at the fixed dosage and continuous infusion protocols.
T84 15252-15398 Sentence denotes Tissue plasminogen activator (tPA) has been used for COVID-19-associated ARDS and patients with refractory microthromboembolic complications.43,44
T85 15399-15552 Sentence denotes It is not always possible to achieve desirable outcome with pharmacological agents, and patients may carry contraindications to pharmacologic approaches.
T86 15553-15702 Sentence denotes In these patients, especially those with concerns of bleeding complications, other modalities such as nonpharmacologic approaches must be considered.
T87 15703-15903 Sentence denotes Dependent on risk status of the patient, and the concerns of bleeding especially ischemic stroke, nonpharmacologic approaches with or without concomitant pharmacologic treatments should be considered.
T88 15904-16239 Sentence denotes The primary action of nonpharmacologic modalities is to reduce the stasis component of Virchow’s triad (stasis, endothelial injury, prothrombotic blood factors).45 Nonpharmacologic approaches include thromboprophylatic stockings, mechanical compression devises, calf compression pumps, and electrical neuromuscular stimulation devices.
T89 16240-16368 Sentence denotes Compression stockings protect against venous stasis by a mechanical manipulation in the nonparalyzed or nonanesthetized patient.
T90 16369-16587 Sentence denotes Venous flow induced by involuntary or habitual muscle movement is augmented by the external compressive counterforce.46 Stockings also reduce venous volume and, in consequence, the venous load available for thrombosis.
T91 16588-17030 Sentence denotes Sequential intermittent pneumatic compression devices, applied around the calf and foot, protect against DVT by pumping venous blood toward the heart.47 The calf muscles can be induced to contract by electrical stimulation applied directly over the muscle bellies of gastrocnemius or indirectly over the common peroneal nerve.48,49 These nonpharmacologic modalities may play a vital role in VTE prophylaxis in patients infected with COVID-19.
T92 17032-17062 Sentence denotes Catheter-Directed Thrombolysis
T93 17063-17280 Sentence denotes Recent data have suggested an increased incidence of PE in COVID-19 patients.50 It is therefore important to identify the risk of PE in COVID-19 patients in order to optimize treatment modalities and clinical outcome.
T94 17281-17431 Sentence denotes Intravenous administration of antithrombotic and thrombolytic therapy has been anecdotally used, with scattered reports of acute improved oxygenation.
T95 17432-17598 Sentence denotes A more localized approach is warranted: catheter-directed thrombolysis (CDT) may prove to be effective with the use of a Swan-Ganz catheter in the pulmonary arteries.
T96 17599-17723 Sentence denotes Catheter-directed thrombolysis can be performed bedside, and imaging is not required to successfully complete the procedure.
T97 17724-17805 Sentence denotes Adjunct local delivery of antivirals and/or interleukin 6 inhibitors is feasible.
T98 17806-17925 Sentence denotes Additionally, the use of catheter-based mechanical thrombectomy devices also needs to be considered when PE is present.
T99 17926-18003 Sentence denotes However, these approaches do pose several logistical and clinical challenges.
T100 18004-18220 Sentence denotes During the prodromal period or period of illness, patients with COVID-19 are highly contagious in which the virus may spread via droplets or become aerosolized during intubation or other aerosol-producing conditions.
T101 18221-18401 Sentence denotes Therefore, the physical movement and intervention of these patients in interventional radiology suites need to be highly controlled to minimize the risk of nosocomial transmission.
T102 18402-18509 Sentence denotes Feasibility studies will help determine the safety and preliminary efficacy of local thrombolytic delivery.
T103 18511-18531 Sentence denotes Other Considerations
T104 18533-18552 Sentence denotes Convalescent Plasma
T105 18553-18688 Sentence denotes Several studies have reported on the successful use of plasma obtained from recently recovered patients to treat the COVID-19 patients.
T106 18689-18837 Sentence denotes This plasma was referred to as convalescent plasma that contains neutralizing antibodies capable of reducing viral load and associated pathogenesis.
T107 18838-19337 Sentence denotes Food and Drug Administration has issued guidance to provide recommendations to health care providers and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19.51 Several recent reports have provided evidence for improved outcome in patients treated with convalescent plasma.52–55 Various national and international studies are ongoing on the use of convalescent plasma in the management of COVID-19 patients.
T108 19339-19366 Sentence denotes Transarterial Drug Delivery
T109 19367-19511 Sentence denotes Transarterial drug delivery to the lungs could prove to be another avenue for local drug delivery to combat coagulopathies with specific agents.
T110 19512-19656 Sentence denotes Acute respiratory distress syndrome likely leads to blood delivery decrease from the pulmonary circulation as well as the bronchial circulation.
T111 19657-19721 Sentence denotes The former may be partially overcome by intrapulmonary delivery.
T112 19722-19876 Sentence denotes The latter leads to dilation of the bronchial arteries, thereby allowing easy cannulation and rendering them an alternative venue for local drug delivery.
T113 19877-20037 Sentence denotes Transarterial local drug delivery is a well-established procedure, including drug therapy/delivery in the lungs via the bronchial arteries using microcatheters.
T114 20038-20251 Sentence denotes The physician is free to choose their therapeutic of choice, given that many identified COVID-19 drug candidates can be administered through a catheter or may be easily formulated in the pharmacy for this purpose.
T115 20253-20278 Sentence denotes Hyperbaric Oxygen Therapy
T116 20279-20403 Sentence denotes Several studies have suggested that hyperbaric oxygen therapy can effectively restore systemic hypoxia in COVID-19 patients.
T117 20404-20593 Sentence denotes Early hyperbaric oxygen therapy may improve the overall systemic supportive treatment, reduce the use of mechanical ventilation, and improve the outcome in critically ill COVID-19 patients.
T118 20594-20728 Sentence denotes Preliminary evidence strongly suggest that hyperbaric oxygen therapy is useful in severely hypoxemic COVID-19 pneumonia patients.56,57
T119 20730-20762 Sentence denotes Primary and Secondary Prevention
T120 20763-20893 Sentence denotes Another vexing problem is how to provide primary and secondary prevention in COVID-19 patients with coronary artery disease (CAD).
T121 20894-21059 Sentence denotes Specifically, the role of antiplatelet agents (ie, clopidogrel, prasugrel, ticagrelor, and cilostazol) with SARS-CoV-2 pathogenesis needs to be further investigated.
T122 21060-21350 Sentence denotes There are some evidence phosphodiesterase inhibitors such as dipyridamole are effective in patients with severely ill COVID 19.58 Additionally, there is little understanding on the possible interactions of these pharmaceuticals with the current drugs being evaluated for COVID-19 treatment.
T123 21352-21370 Sentence denotes Acute Heart Injury
T124 21371-21692 Sentence denotes There is no consensus on the approach to treat the COVID-19 patients with acute heart injury, which occurs in 6% to 18% of cases.59 The variability in the proportion of acute heart injury may be explained by many factors including insufficient data collection, lack of biomarkers, and other suitable testing capabilities.
T125 21693-21792 Sentence denotes Currently, we are limited to using treatment strategies based on etiology of the heart injury.59,60
T126 21793-21861 Sentence denotes SARS-CoV-2 itself is a likely culprit to produce acute heart injury.
T127 21862-22074 Sentence denotes However, difficulties to perform magnetic resonance imaging, myocardial biopsy, and computed tomography angiography, have made the diagnosis and understanding of the mechanism of injury complicated and empirical.
T128 22075-22167 Sentence denotes One potential mechanism could be acute coronary syndrome in the absence of CAD in anamnesis.
T129 22168-22330 Sentence denotes Several groups have suggested the use of systemic tPA in cases of progression of existing cardiovascular disease; however, perhaps PCI may be an optimal strategy.
T130 22331-22456 Sentence denotes Further investigation and standardization are required prior to recommending any of the traditional anticoagulant treatments.
T131 22458-22492 Sentence denotes Risk of Stroke in Younger Patients
T132 22493-22567 Sentence denotes There is a concerning number of strokes in younger patients with COVID-19.
T133 22568-22642 Sentence denotes Aggressive investigation is required to better understand this phenomenon.
T134 22643-22832 Sentence denotes Intravenous administration of tPA and more aggressive interventional approaches using catheter-based mechanical thrombectomy devices may be warranted in these patients with serious disease.
T135 22834-22844 Sentence denotes Conclusion
T136 22845-22967 Sentence denotes The burden and reach of COVID-19 continues to grow, though early public health interventions may have flattened the curve.
T137 22968-23094 Sentence denotes However, there remains a large population, globally, hospitalized from COVID-19 with many more anticipated to be hospitalized.
T138 23095-23217 Sentence denotes There is no singular treatment shown to be effective in combatting COVID-19 and vaccines are currently being investigated.
T139 23218-23327 Sentence denotes COVID-19 is largely localized to the lungs, and the development of COVID-19 coagulopathies is a real concern.
T140 23328-23389 Sentence denotes There is much more research that is required to be performed.
T141 23390-23536 Sentence denotes Based upon the evidence we currently have, the heparins and other anticoagulants may provide effective prophylaxis against clinical deterioration.
T142 23537-23620 Sentence denotes The dosage regimen of the heparins requires further investigation for optimization.
T143 23621-23703 Sentence denotes The role of antiplatelet therapy as preventive measure also needs to be addressed.
T144 23704-23818 Sentence denotes Patients currently on antiplatelets may require special attention, as well as those developing acute heart injury.
T145 23819-23993 Sentence denotes Finally, local drug delivery of any of the identified COVID-19 drug candidates in combination of anticoagulation and antithrombotic therapies may increase treatment efficacy.
T146 23995-24010 Sentence denotes Acknowledgments
T147 24011-24182 Sentence denotes The authors gratefully acknowledge the helpful advice from Dr Alfonso Tafur of Northshore Cardiovascular Institute, NorthShore University Health Systems, Skokie, Illinois.
T148 24183-24344 Sentence denotes The authors are also thankful to Mrs Erin Healy-Erickson from Loyola University Chicago, Health Science Division, Maywood, Illinois in preparing this manuscript.
T149 24345-24382 Sentence denotes Declaration of Conflicting Interests:
T150 24383-24518 Sentence denotes The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
T151 24519-24527 Sentence denotes Funding:
T152 24528-24637 Sentence denotes The author(s) received no financial support for the research, authorship, and/or publication of this article.
T153 24638-24647 Sentence denotes ORCID iD:
T154 24648-24702 Sentence denotes Fakiha Siddiqui https://orcid.org/0000-0002-2219-7049
T155 24703-24713 Sentence denotes Charles A.
T156 24714-24759 Sentence denotes Carter https://orcid.org/0000-0002-4302-0402
T157 24760-24811 Sentence denotes Jawed Fareed https://orcid.org/0000-0003-3465-2499

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 6-18 Phenotype denotes Coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T2 719-731 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T3 746-764 Phenotype denotes pulmonary embolism http://purl.obolibrary.org/obo/HP_0002204
T4 896-916 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T5 933-945 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T6 1127-1165 Phenotype denotes disseminated intravascular coagulation http://purl.obolibrary.org/obo/HP_0005521
T7 1846-1864 Phenotype denotes pulmonary embolism http://purl.obolibrary.org/obo/HP_0002204
T8 3140-3160 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T9 3307-3319 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T10 3384-3398 Phenotype denotes coagulopathies http://purl.obolibrary.org/obo/HP_0003256
T11 5200-5212 Phenotype denotes Coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T12 5433-5447 Phenotype denotes coagulopathies http://purl.obolibrary.org/obo/HP_0003256
T13 5469-5487 Phenotype denotes pulmonary embolism http://purl.obolibrary.org/obo/HP_0002204
T14 5489-5491 Phenotype denotes PE http://purl.obolibrary.org/obo/HP_0002204
T15 5887-5909 Phenotype denotes respiratory infections http://purl.obolibrary.org/obo/HP_0011947
T16 6021-6037 Phenotype denotes thrombocytopenia http://purl.obolibrary.org/obo/HP_0001873
T17 6471-6480 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T18 6502-6514 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T19 6622-6627 Phenotype denotes edema http://purl.obolibrary.org/obo/HP_0000969
T20 6739-6762 Phenotype denotes diffuse alveolar damage http://purl.obolibrary.org/obo/HP_0033006
T21 6803-6816 Phenotype denotes bronchiolitis http://purl.obolibrary.org/obo/HP_0011950
T22 6880-6896 Phenotype denotes hemophagocytosis http://purl.obolibrary.org/obo/HP_0012156
T23 7471-7509 Phenotype denotes disseminated intravascular coagulation http://purl.obolibrary.org/obo/HP_0005521
T24 7511-7514 Phenotype denotes DIC http://purl.obolibrary.org/obo/HP_0005521
T25 7581-7597 Phenotype denotes thrombocytopenia http://purl.obolibrary.org/obo/HP_0001873
T26 7881-7897 Phenotype denotes thrombocytopenia http://purl.obolibrary.org/obo/HP_0001873
T27 7938-7954 Phenotype denotes thrombocytopenia http://purl.obolibrary.org/obo/HP_0001873
T28 8043-8057 Phenotype denotes coagulopathies http://purl.obolibrary.org/obo/HP_0003256
T29 8661-8688 Phenotype denotes antiphospholipid antibodies http://purl.obolibrary.org/obo/HP_0003613
T30 8741-8768 Phenotype denotes antiphospholipid antibodies http://purl.obolibrary.org/obo/HP_0003613
T31 9204-9216 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T32 9838-9854 Phenotype denotes elevated d-dimer http://purl.obolibrary.org/obo/HP_0033106
T33 10249-10263 Phenotype denotes coagulopathies http://purl.obolibrary.org/obo/HP_0003256
T34 10511-10526 Phenotype denotes thromboembolism http://purl.obolibrary.org/obo/HP_0001907
T35 11247-11264 Phenotype denotes venous thrombosis http://purl.obolibrary.org/obo/HP_0004936
T36 11397-11400 Phenotype denotes DIC http://purl.obolibrary.org/obo/HP_0005521
T37 12292-12308 Phenotype denotes thrombocytopenia http://purl.obolibrary.org/obo/HP_0001873
T38 12943-12952 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T39 13038-13055 Phenotype denotes acute lung injury http://www.orpha.net/ORDO/Orphanet_178320
T40 13189-13226 Phenotype denotes chronic obstructive pulmonary disease http://purl.obolibrary.org/obo/HP_0006510
T41 13237-13250 Phenotype denotes lung diseases http://purl.obolibrary.org/obo/HP_0002088
T42 15784-15799 Phenotype denotes ischemic stroke http://purl.obolibrary.org/obo/HP_0002140
T43 17116-17118 Phenotype denotes PE http://purl.obolibrary.org/obo/HP_0002204
T44 17193-17195 Phenotype denotes PE http://purl.obolibrary.org/obo/HP_0002204
T45 17911-17913 Phenotype denotes PE http://purl.obolibrary.org/obo/HP_0002204
T46 19475-19489 Phenotype denotes coagulopathies http://purl.obolibrary.org/obo/HP_0003256
T47 19518-19538 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T48 20374-20381 Phenotype denotes hypoxia http://purl.obolibrary.org/obo/HP_0012418
T49 20704-20713 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T50 22258-22280 Phenotype denotes cardiovascular disease http://purl.obolibrary.org/obo/HP_0001626
T51 22466-22472 Phenotype denotes Stroke http://purl.obolibrary.org/obo/HP_0001297
T52 22568-22578 Phenotype denotes Aggressive http://purl.obolibrary.org/obo/HP_0000718
T53 23294-23308 Phenotype denotes coagulopathies http://purl.obolibrary.org/obo/HP_0003256

2_test

Id Subject Object Predicate Lexical cue
32687449-32031570-21622984 2657-2658 32031570 denotes 1
32687449-32125362-21622985 2659-2660 32125362 denotes 2
32687449-32142651-21622986 4001-4002 32142651 denotes 3
32687449-15141377-21622987 4209-4210 15141377 denotes 4
32687449-32159775-21622988 4416-4417 32159775 denotes 5
32687449-11169526-21622989 4525-4526 11169526 denotes 6
32687449-16019455-21622990 6075-6077 16019455 denotes 12
32687449-20551263-21622991 6897-6899 20551263 denotes 14
32687449-19875682-21622991 6897-6899 19875682 denotes 14
32687449-20154276-21622991 6897-6899 20154276 denotes 14
32687449-20420734-21622991 6897-6899 20420734 denotes 14
32687449-21288835-21622992 7285-7287 21288835 denotes 19
32687449-16019455-21622993 7430-7432 16019455 denotes 12
32687449-32171076-21622994 8026-8028 32171076 denotes 20
32687449-32305883-21622995 8162-8164 32305883 denotes 21
32687449-22930518-21622996 8593-8595 22930518 denotes 22
32687449-23645692-21622997 9825-9827 23645692 denotes 24
32687449-32316065-21622998 10675-10677 32316065 denotes 25
32687449-17727922-21622999 11815-11817 17727922 denotes 30
32687449-19888515-21622999 11815-11817 19888515 denotes 30
32687449-11518721-21622999 11815-11817 11518721 denotes 30
32687449-28063994-21622999 11815-11817 28063994 denotes 30
32687449-10556136-21623000 12734-12736 10556136 denotes 35
32687449-27288618-21623000 12734-12736 27288618 denotes 35
32687449-29142373-21623001 12842-12844 29142373 denotes 38
32687449-18460218-21623002 13111-13113 18460218 denotes 39
32687449-28986203-21623003 13277-13279 28986203 denotes 40
32687449-21816542-21623003 13277-13279 21816542 denotes 40
32687449-32281766-21623004 15396-15398 32281766 denotes 44
32687449-15692260-21623005 16065-16067 15692260 denotes 45
32687449-22315261-21623006 16738-16740 22315261 denotes 47
32687449-20650668-21623007 16914-16916 20650668 denotes 48
32687449-32253318-21623008 19203-19205 32253318 denotes 52
32687449-32219428-21623008 19203-19205 32219428 denotes 52